PI Industries is a leading player in the agro-chemicals space with strong presence in both domestic and export markets, featuring state-of-the-art facilities in Gujarat with integrated process development teams and in-house engineering capabilities. The company is almost debt-free with a focus on innovation in crop protection and plant health solutions.
Cyborg Score Rationale
The company reported robust 186% year-on-year growth in its pharma business and is developing over 20 new products with a strong order book of approximately $1.2 billion, though it faces headwinds from declining commodity prices and regulatory challenges. Recent performance shows modest revenue growth with margin pressures.
Top Insights
Pharma business achieved 186% year-on-year growth despite commodity price pressures and regulatory challenges in biologicals
Pipeline includes 20+ new products with $1.2B order book, highlighting significant growth in electronic chemicals and pest management
FY2025 revenue reached ₹79.78 billion, a 4.07% increase from prior year
Company has strong financial metrics: ROCE of 22.9%, ROE of 17.6%, and minimal debt burden
Named Competitors
UPL — Diversified agrochemical manufacturer
Navin Fluorine — Specialty chemicals and agrochemicals
Bharat Rasayan — Chemical manufacturer and distributor
Recent Developments
(February 2026) Board meeting held to review Q3 FY26 performance amid export and regulatory challenges
(June 2025) Net profit declined 10.87% to Rs 400 crore; sales fell 8.14% YoY to Rs 1,900.50 crore
(August 2025) 78th Annual General Meeting conducted; Morgan Stanley upgraded stock to 'Overweight' with ₹5,000 target in June
Open the full interactive PI Industries Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.